Skip to main content
رجوع
Watch Compare

LianBio

جودة البيانات: 83%
LIANY
OTC Manufacturing Chemicals
KWD 0.12
KWD 0.00 (0.00%)
القيمة السوقية: 13.20 M
السعر
KWD 0.12
القيمة السوقية
13.20 M
نطاق اليوم
KWD 0.12 — KWD 0.12
نطاق 52 أسبوعًا
KWD 0.03 — KWD 0.44
حجم التداول
575
فتح KWD 0.12
متوسط 50 يوم / 200 يوم
KWD 0.11
5.77% above
متوسط 50 يوم / 200 يوم
KWD 0.11
9.50% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -83.99 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-41.49%
أعلى من متوسط القطاع (-53.47%)
ROIC-34.05%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio10.06
Interest Coverage-10.71

التقييم

PE (TTM)
-0.15
أعلى من متوسط القطاع (-1.47)
P/B Ratio0.07
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.2 -1.5
P/B 0.1 1.6
ROE % -41.5 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -87.98 M
ROE -41.49% ROA -32.48%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -83.99 M
ROIC -34.05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10.06
Interest Coverage -10.71 Asset Turnover N/A
Working Capital 232.18 M Tangible Book Value 202.34 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.15 Forward P/E N/A
P/B Ratio 0.07 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -636.09%
Market Cap 13.20 M Enterprise Value -90.25 M
Per Share
EPS (Diluted TTM) -0.82 Revenue / Share N/A
FCF / Share -0.77 OCF / Share -0.77
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 95.46%
SBC-Adj. FCF -102.04 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021
Revenue — —
Net Income -110.29 M -196.30 M
EPS (Diluted) -1.02 -5.71
Gross Profit — —
Operating Income -125.35 M -195.57 M
EBITDA — —
R&D Expenses 59.76 M 158.69 M
SG&A Expenses — —
D&A — —
Interest Expense 4.32 M 243,000.0
Income Tax -333,000.0 518,000.0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021
Total Assets 319.96 M 426.34 M
Total Liabilities 26.31 M 39.01 M
Shareholders' Equity 259.87 M 353.56 M
Total Debt — —
Cash & Equivalents 79.22 M 228.18 M
Current Assets 312.77 M 399.65 M
Current Liabilities 23.62 M 15.09 M